Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Janet Dunn, Claire Hulme et al.|The Lancet Oncology|2019

Cited by 160